Avantor, Inc. (AVTR) Income Statement Analysis

See more : Spiffbet AB (SPIFF.ST) Income Statement Analysis – Financial Results

Complete financial analysis of Avantor, Inc. (AVTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avantor, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.

You may be interested

Immunotech Biopharm Ltd (6978.HK) Income Statement Analysis – Financial Results
Zhejiang Crystal-Optech Co., Ltd (002273.SZ) Income Statement Analysis – Financial Results
Velocity Energy Inc. (VCYE) Income Statement Analysis – Financial Results
Leo Holdings Corp. II Redeemabl (LHC-WT) Income Statement Analysis – Financial Results
Sparinvest Mix Maksimum Risiko (SPIMMRIA.CO) Income Statement Analysis – Financial Results

Avantor, Inc. (AVTR)

Industry: Chemicals - Specialty

Sector: Basic Materials

Website: https://www.avantorsciences.com

About Avantor, Inc.

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2001
Revenue	6.97B	7.51B	7.39B	6.39B	6.04B	5.86B	1.25B	691.30M	636.90M	4.91B
Cost of Revenue	4.60B	4.91B	4.88B	4.31B	4.12B	4.04B	814.60M	371.60M	374.70M	2.31B
Gross Profit	2.36B	2.60B	2.50B	2.08B	1.92B	1.82B	432.80M	319.70M	262.20M	2.60B
Gross Profit Ratio	33.93%	34.65%	33.88%	32.54%	31.80%	31.03%	34.70%	46.25%	41.17%	53.01%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.10M	21.90M	0.00
General & Administrative	0.00	0.00	0.00	1.37B	1.37B	1.41B	643.20M	309.80M	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	1.51B	1.47B	1.53B	1.37B	1.37B	1.41B	643.20M	309.80M	201.60M	1.47B
Other Expenses	0.00	-800.00K	10.60M	9.90M	2.50M	3.00M	3.40M	200.00K	-300.00K	0.00
Operating Expenses	1.66B	1.47B	1.53B	1.37B	1.37B	1.41B	643.20M	309.80M	201.90M	1.47B
Cost & Expenses	6.26B	6.38B	6.41B	5.69B	5.49B	5.45B	1.46B	681.40M	576.60M	3.78B
Interest Income	0.00	265.80M	229.30M	307.60M	440.00M	0.00	0.00	0.00	30.60M	0.00
Interest Expense	284.80M	265.80M	217.40M	307.60M	440.00M	523.80M	200.90M	80.30M	0.00	-265.80M
Depreciation & Amortization	402.30M	405.50M	379.20M	395.40M	398.90M	404.60M	99.20M	60.30M	60.70M	0.00
EBITDA	1.13B	1.53B	1.35B	765.30M	879.50M	814.60M	-91.20M	70.40M	121.10M	1.13B
EBITDA Ratio	16.19%	20.43%	18.44%	17.39%	15.78%	14.00%	-8.64%	10.18%	19.00%	23.02%
Operating Income	696.40M	1.13B	972.20M	706.80M	551.80M	413.50M	-210.40M	9.90M	60.30M	1.13B
Operating Income Ratio	10.00%	15.04%	13.16%	11.05%	9.14%	7.05%	-16.87%	1.43%	9.47%	23.02%
Total Other Income/Expenses	-285.90M	-279.10M	-219.20M	-644.50M	-511.20M	-527.30M	-249.80M	-80.50M	-30.50M	-279.10M
Income Before Tax	410.50M	851.10M	753.00M	62.30M	40.60M	-113.80M	-460.20M	-70.60M	29.80M	851.10M
Income Before Tax Ratio	5.89%	11.33%	10.19%	0.97%	0.67%	-1.94%	-36.89%	-10.21%	4.68%	17.34%
Income Tax Expense	89.40M	164.60M	180.40M	-54.30M	2.80M	-26.90M	-314.90M	10.10M	17.10M	-164.60M
Net Income	321.10M	686.50M	572.60M	116.60M	37.80M	-86.90M	-112.70M	-42.40M	21.60M	686.50M
Net Income Ratio	4.61%	9.14%	7.75%	1.82%	0.63%	-1.48%	-9.03%	-6.13%	3.39%	13.98%
EPS	0.48	1.02	0.86	0.20	-0.84	-0.18	-0.23	-0.09	0.04	1.05
EPS Diluted	0.47	1.01	0.85	0.20	-0.84	-0.18	-0.23	-0.09	0.04	1.01
Weighted Avg Shares Out	675.60M	650.90M	590.50M	576.30M	401.20M	496.50M	496.50M	491.30M	534.29M	650.90M
Weighted Avg Shares Out (Dil)	678.40M	679.40M	599.60M	583.40M	401.20M	496.50M	496.50M	491.30M	534.29M	679.40M

ELV vs. AVTR: Which Stock Is the Better Value Option?

February 2, 2024zacks.com

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?

Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024

January 24, 2024prnewswire.com

RADNOR, Pa. , Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and...

Avantor® Recognizes Supplier Award Winners at 2024 Americas Sales Conference

January 19, 2024prnewswire.com

RADNOR, Pa. , Jan. 19, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, kicked off the year at the 2024 Americas Sales Conference...

Avantor® to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 3, 2024prnewswire.com

RADNOR, Pa. , Jan. 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that Michael Stubblefield, President and CEO, will present at the...

Avantor® Hosts Investor Day, Announces New Strategic Operating Model to Drive Growth and Productivity

December 7, 2023prnewswire.com

Transformative New Operating Model to Feature Two Complementary Business Segments Aligned to Customer Needs: Laboratory Solutions and Bioscience Production Company Launches Cost Optimization Initiative to Deliver $300M in Run Rate Savings by the end of 2026 Reaffirms Fiscal Year 2023...

Avantor® Receives Top Score on Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index

November 30, 2023prnewswire.com

RADNOR, Pa. , Nov. 30, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries received a score of 100 on the Human Rights Campaign...

Avantor® to Host Investor Day on December 8, 2023

November 22, 2023prnewswire.com

RADNOR, Pa. , Nov. 22, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that the company will host an Investor Day on...

Avantor® to Participate in the 6th Annual Evercore ISI HealthCONx Conference

November 16, 2023prnewswire.com

RADNOR, Pa. , Nov. 16, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that President and CEO Michael Stubblefield, will be participating in...

Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite

November 15, 2023zacks.com

Avantor's (AVTR) latest offerings are likely to provide its customers with products, materials and services that would aid in accelerating therapeutics.